Top 10 Most Popular Infection Control Today Articles of 2022: 4, 3, 2
This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 4th, 3rd, and 2nd most popular.
Infection Control Today® (ICT®) strives all year to give you the best, most helpful information to do your job. Starting with the tenth most popular article, we will countdown the Top 10 most popular articles ICT® posted in 2022.
Here we continue our countdown with the 4th, 3rd, and 2nd most popular articles ICT® posted in 2022.
4th Most Popular: Contamination of Point-of-Care Ultrasound Transducers Alarms Key Clinician
Using ultrasound transducers is often necessary in the emergency department, but too often the proper procedures to protect against health care-associated infections are not followed, and clinicians are worried.
3rd Most Popular: Candida auris Rapidly Recontaminates Surfaces Around Patients’ Beds Despite Cleaning and Disinfection
Candida auris environmental contamination is unlikely to be adequately controlled because re-contamination occurs within hours after disinfection.
2nd Most Popular: The FDA Issues Urgent Warning About Karl Storz Endoscopes Reprocessing Methods
The letter comes after a year of reprocessing validation testing and a voluntary medical device recall.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
